Skip to main content
Premium Trial:

Request an Annual Quote

Lumera Signs Up ISB to Develop Label-Free Protein Array System

NEW YORK, Feb. 14 (GenomeWeb News) - Lumera will collaborate with the Institute for Systems Biology to develop a label-free protein microarray platform, the Bothell, Wash.-based company said today.

 

The platform will include Lumera's NanoCapture microarrays and its ProteomicProcessor reader, which does not require molecular labels. The new system will enable researchers to perform real-time kinetic measurements of protein-protein, protein-drug, and protein-DNA interactions.

 

Lumera plans to bring the technology to market "as quickly as possible," according to a company statement.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.